Freestone Capital Holdings’s Biodesix BDSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDSX
BC
ACM
KCM
PI
OIM
FAM
RI
Freestone Capital Holdings's BDSX Position: Q1 2021 in Review
Freestone Capital Holdings sold out of Biodesix (BDSX) in Q1 2021, closing a stake of 20 shares — an estimated $8.06K sold.
Freestone Capital Holdings first reported a position in BDSX in Q4 2020 and held it in 1 quarter. The position peaked at $8.06K in Q4 2020. 46 funds tracked by Wall St. Rank hold BDSX as of Q1 2021.
- Freestone Capital Holdings reported no remaining Biodesix position as of Q1 2021 after selling out during the quarter.
- Freestone Capital Holdings sold 20 Biodesix shares in Q1 2021, an estimated $8.06K.
- Freestone Capital Holdings first reported a position in Biodesix in Q4 2020 and held it in 1 quarter.
- Freestone Capital Holdings's Biodesix position peaked at $8.06K in Q4 2020.
- 46 funds tracked by Wall St. Rank held Biodesix as of Q1 2021.
Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.